Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial. JAMA Oncol. 2020 09 01; 6(9):1355-1362.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Bridged-Ring Compounds
Cyclophosphamide
Disease-Free Survival
Doxorubicin
Female
Humans
Middle Aged
Neoadjuvant Therapy
Neoplasm Recurrence, Local
Proportional Hazards Models
Receptor, ErbB-2
Taxoids
Trastuzumab
Treatment Outcome

authors with profiles

Rita Nanda
Husain Sattar
Jeffrey B. Matthews
Olufunmilayo Olopade